Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training

Circulation

Volumn 101, Issue 18, 2000, Pages 2134-2137

  Eto, Yoko ^a   Yonekura, Katsunori ^a   Sonoda, Makoto ^a   Arai, Naoto ^a   Sata, Masataka ^a   Sugiura, Seiryo ^a   Takenaka, Katsu ^a   Gualberto, Antonio ^b,c   Hixon, Mary L ^b   Wagner, Mark W ^b   Aoyagi, Teruhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Exercise; Hypertrophy; Signal transduction

Indexed keywords

CALCINEURIN; CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXERCISE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; HEART STROKE VOLUME; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0034625078     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.18.2134     Document Type: Article

References (15)

1. Barry JM. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol. 1986;7:190-203.
2. Devereux RB. Left ventricular geometry, pathophysiology, and prognosis. J Am Coll Cardiol. 1995;25:885-887.
3. Molkentin JD, Lu J-R, Antos CL, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228.
4. Sussman MA, Lim HW, Gude N, et al. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998;281:1690-1693.
5. Meguro T, Hong C, Asai K, et al. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res. 1999;84:735-740.
6. Luo Z, Shyu K-G, Gualberto A, et al. Calcineurin inhibitors and cardiac hypertrophy. Nat Med. 1998;4:1092-1093.
7. Ding B, Price RL, Borg TK, et al. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res. 1999;84:729-734.
8. Zhang W, Kowal RC, Rusnak F, et al. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res. 1999;84:722-728.
9. 2+-ATPase (SERCA2) gene promoter activity is in response to severe left ventricular pressure-overload hypertrophy in rat hearts. J Mol Cell Cardiol. 1999;31:919-926.
10. Gualberto A, Marquez G, Carballo M, et al. p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. J Biol Chem. 1998;273:7088-7093.
11. Su Q, Zhao M, Weber E, et al. Distribution and activity of calcineurin in rat tissues: evidence for post-transcriptional regulation of testis-specific calcineurin B. Eur J Biochem. 1995;230:469-474.
12. Schaible T, Malhotra A, Ciambrone G, et al. Combined effects of hypertension and chronic running program on rat heart. J Appl Physiol. 1987; 63:322-327.
13. Moore RL, Musch TI, Yelamarty RV, et al. Chronic exercise alters contractility and morphology of isolated rat cardiac myocytes. Am J Physiol. 1993;264:C1180-C1189.
14. Lim HW, Molkentin JD. Calcineurin and human heart failure. Nat Med. 1999;5:246-247.
15. Tsao L, Neville C, Musaro A, et al. Revisiting calcineurin and human heart failure. Nat Med. 2000;6:2-3.